Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;326:1265 (7 June), doi:10.1136/bmj.326.7401.1265-a
| The first 150 words of the full text of this article appear below. |
EDITORThe article by Helms et al raises the importance of case selection and clinical data on the estimates of short and long term mortality from clinical illness.1 Clinicians' understanding of an illness entails identifying symptoms and signs, in relation to age, sex, and geography, the three variables for which the authors selected controls. But clinicians also decide on the necessity for diagnostic laboratory tests. Results deemed unlikely to influence patients' management or outcome affect the likelihood of investigation.2 Variations in laboratory testing protocols and methods affect what is detected and reported.3
Medical epidemiologists are aware that the infecting dose affects severity. In general, the larger the infecting dose, the more severe the illness and the more likely the patient is to present to a clinician,4 so that severe illnesses are more likely to be represented in those studied.
Medical microbiologists are aware, as acknowledged by the authors, that
Sarah J O'Brien, head of gastrointestinal diseases division
Health Protection Agency, Communicable Disease Surveillance Centre, London NW9 5EQ sarah.o'brien@hpa.org.uk
Roger A Feldman, emeritus professor of clinical epidemiology
Barts and the London, Queen Mary School of Medicine and Dentistry, University of London E1 2AD